Elizabeth Evans to Prisons
This is a "connection" page, showing publications Elizabeth Evans has written about Prisons.
Connection Strength
0.892
-
Anglin MD, Nosyk B, Jaffe A, Urada D, Evans E. Offender diversion into substance use disorder treatment: the economic impact of California's proposition 36. Am J Public Health. 2013 Jun; 103(6):1096-102.
Score: 0.389
-
Evans EA, Pivovarova E, Senthilkumar R, Rottapel RE, Stopka TJ, Santelices C, Ferguson WJ, Friedmann PD. Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts. Int J Drug Policy. 2023 Dec; 122:104252.
Score: 0.202
-
Donelan CJ, Hayes E, Potee RA, Schwartz L, Evans EA. COVID-19 and treating incarcerated populations for opioid use disorder. J Subst Abuse Treat. 2021 05; 124:108216.
Score: 0.165
-
Bovell-Ammon BJ, Yan S, Dunn D, Evans EA, Friedmann PD, Walley AY, LaRochelle MR. Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes. JAMA Netw Open. 2024 03 04; 7(3):e242732.
Score: 0.052
-
Krebs E, Urada D, Evans E, Huang D, Hser YI, Nosyk B. The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addiction. 2017 May; 112(5):838-851.
Score: 0.032
-
Hser YI, Evans E, Huang D, Messina N. Long-term outcomes among drug-dependent mothers treated in women-only versus mixed-gender programs. J Subst Abuse Treat. 2011 Sep; 41(2):115-23.
Score: 0.021
-
Hser YI, Evans E, Teruya C, Huang D, Anglin MD. Predictors of short-term treatment outcomes among California's Proposition 36 participants. Eval Program Plann. 2007 May; 30(2):187-96.
Score: 0.016
-
Hser YI, Teruya C, Brown AH, Huang D, Evans E, Anglin MD. Impact of California's Proposition 36 on the drug treatment system: treatment capacity and displacement. Am J Public Health. 2007 Jan; 97(1):104-9.
Score: 0.016